haloperidol has been researched along with Diathesis in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine-treated rats also had higher catalepsy latency scores compared with control rats (P<0." | 1.35 | Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine. ( Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL; Heredia-López, FJ; Moo-Puc, RE; Pineda, JC; Villanueva-Toledo, JR, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Góngora-Alfaro, JL | 1 |
| Moo-Puc, RE | 1 |
| Villanueva-Toledo, JR | 1 |
| Alvarez-Cervera, FJ | 1 |
| Bata-García, JL | 1 |
| Heredia-López, FJ | 1 |
| Pineda, JC | 1 |
| Oganesian, GA | 1 |
| Vataev, SI | 1 |
| Titkov, ES | 1 |
2 other studies available for haloperidol and Diathesis
| Article | Year |
|---|---|
Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
Topics: Animals; Caffeine; Catalepsy; Central Nervous System Stimulants; Disease Susceptibility; Dopamine D2 | 2009 |
[Corticostriatal relations in the waking-sleep cycle of normal rats and in pathology].
Topics: Acoustic Stimulation; Animals; Catalepsy; Caudate Nucleus; Cerebral Cortex; Disease Susceptibility; | 1997 |